Results 221 to 230 of about 412,223 (311)

Risk of new-onset diabetes across individual statins in secondary prevention: results from the Korean national health insurance service cohort. [PDF]

Front Cardiovasc Med
Park EJ, Park Y, Kang DO, Park S, Roh SY, Na JO, Kim JW, Kim EJ, Rha SW, Park CG, Choi CU.   +10 more
europepmc   +1 more source

Switching disease‐modifying therapies in patients with spinal muscular atrophy: A systematic review on effectiveness outcomes

British Journal of Clinical Pharmacology, EarlyView.
With multiple disease‐modifying therapies now available, treatment switching has become an important clinical consideration in the management of spinal muscular atrophy (SMA). While some switches are prompted by suboptimal clinical response, more commonly they are driven by treatment burden, convenience, or adverse events.
Andrej Belančić, Elvira Meni Maria Gkrinia, Patrick Eustaquio, Andrea Katrin Faour, Dinko Vitezić   +4 more
wiley   +1 more source

Impact of the COVID-19 pandemic on the utilization of healthcare

Journal of the Formosan Medical Association
Chung-liang Shih, Oliver Liu, You-Jun Lin   +2 more
doaj   +1 more source

Payment compliance of informal sector workers in Indonesia National Health Insurance: a study on ability and willingness to pay. [PDF]

Health Econ Rev
Hidayat MS, Permana YH, Puspandari DA, Siregar DR, Setyaningsih H, Aristianti V, Baros WA, Atsna Z, Fadlika F, Boenjamin A.   +9 more
europepmc   +1 more source

The integration of the British Pharmacological Society's prescription safety assessment into the WHO 6‐step model of rational pharmacotherapy in a Turkish medical school

British Journal of Clinical Pharmacology, EarlyView.
Aims At Koç University School of Medicine, a one‐week rational pharmacotherapy (RPHM) programme, modelled after WHO 6‐step, has been introduced in the fourth‐year curriculum to improve prescription skills. For efficient problem‐based learning (PBL) sessions on a prespecified topic, students need to brush up on basic pharmacology knowledge, so we ...
Sinem Ezgi Gülmez, Gülnihal Özcan, Hakan S. Orer   +2 more
wiley   +1 more source

Perceptions and attitudes of South African physiotherapists towards National Health Insurance. [PDF]

Health SA
Narain S, Mathye D.
europepmc   +1 more source

Trends in the utilization, expenditure and costs of noninsulin glucose‐lowering drugs in the Medicaid population: Steady increases in glucagon‐like peptide‐1 receptor agonist and sodium–glucose transporter‐2 inhibitor use, prices and expenditure

British Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to analyse changes in the utilization, expenditure and average cost of noninsulin glucose‐lowering drugs (GLDs) between 2008 and 2023. Methods This was a retrospective observational study of 2008–2023 data from the National Medicaid State Drug Utilization database.
Rawan O. Almadfaa
wiley   +1 more source

Indonesian National Health Insurance scheme longitudinal sample data 2015-2020: overview and potential uses for health policy analysis. [PDF]

BMC Health Serv Res
Fatimah A, Anselmi L, Gibson J, Maharani A, Irmansyah I, Idaiani S, Susilo D, Wilkinson J, Sutton M, Susanti H, Brooks H, Bee P, Thabrany H.   +12 more
europepmc   +1 more source

Optimization of pharmaceutical research and development by early‐phase assessment of investigational medicinal products

British Journal of Clinical Pharmacology, EarlyView.
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló, Attila Imre, Gábor Varga, Sándor Kovács, György Tímár, Balázs Nagy   +5 more
wiley   +1 more source

Trends in 25 years of antihypertensive agent utilization in Croatia – an alert for scientific community and healthcare providers

British Journal of Clinical Pharmacology, EarlyView.
Aims Hypertension is a leading modifiable risk factor for cardiovascular mortality worldwide. This study aimed to evaluate 25‐year trends in antihypertensive agent (AHA) utilization in Croatia between 2000 and 2024. Methods We conducted a national, population‐based analysis using IMS and IQVIA pharmaceutical databases.
Andrej Belančić, Marta Kučan Štiglić, Ana Jelaković, Bojan Jelaković, Dinko Vitezić   +4 more
wiley   +1 more source